GVR Report cover ELISA Analyzers Market Size, Share & Trends Report

ELISA Analyzers Market Size, Share & Trends Analysis Report By Type (Optical Filter Elisa Analyzer, Optical Grating ELISA Analyzers), By Mode, By Application, By End-user, By Region, And Segment Forecasts, 2023 To 2030

  • Report ID: GVR453988
  • Number of Pages: 0
  • Format: Electronic (PDF)

ELISA (Enzyme-Linked Immunosorbent Assay) is a widely used diagnostic tool that allows for the detection and measurement of specific proteins and antibodies in a sample. ELISA analyzers, which are automated instruments that perform various steps of the assay, provide accurate and reproducible results. These machines are valuable in the diagnosis of diseases such as HIV, hepatitis, and cancer, as well as in research fields like immunology and drug development. ELISA analyzers come in different types, including benchtop and microplate readers, and can be customized to suit specific requirements. With the advancement in technology, ELISA assays can now be performed in portable devices, making them more accessible to people in remote and underserved areas. In May 2022, Molecular Devices, LLC has launched automated work cells for ELISA workflows, which streamline and automate the process of ELISA testing, allowing for faster and more efficient analysis of large volumes of samples.

The ELISA analyzer market is driven by the need for advancements in technology and automation in the medical diagnostics industry. A key example of this is the strategic merger of Gold Standard Diagnostics Inc. with Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH in May 2022, which has expanded the company's product portfolio to include automated ELISA analyzers. ELISA is a widely used diagnostic tool that can detect and measure specific proteins and antibodies in a sample, making it a valuable tool in the diagnosis of diseases such as HIV, hepatitis, and cancer as well as in research fields such as immunology and drug development. Automated ELISA analyzers are designed to provide accurate and reproducible results, further increasing the demand for these devices.

The market is segmented based on type, type of operations, application, end user, and region. The type segment includes optical filter ELISA analyzer and optical grating ELISA analyzers. The mode segment is segmented into automated ELISA analyzers and semi-automated analyzers. Application segment is further segmented into immunology, vaccine development, drug monitoring, and others. The end-user segment is classified into pharmaceutical and biotechnology companies, contract research organization, and diagnostic laboratories.

The ELISA (Enzyme-linked immunosorbent assay) analyzer market is growing rapidly across various regions, with North America and Europe leading the way in terms of market share. In North America, the U.S. and Canada are key players in the market, driven by the presence of a large number of research centers and pharmaceutical companies in the region. Europe, particularly the UK, Germany, France, Italy, Spain, Denmark, Sweden, and Norway, also have a strong ELISA analyzer market, due to the large number of research institutions and government funding for research in these countries. Asia Pacific, specifically Japan, China, India, Australia, Thailand, and South Korea, is also witnessing significant growth in the ELISA analyzer market, driven by increasing investments in research and development and rising prevalence of chronic diseases. Latin America, with Brazil, Mexico, and Argentina as major market players, also presents a significant growth opportunity in ELISA analyzer market. Middle East & Africa also show potential growth in ELISA analyzer market, with countries such as Saudi Arabia, UAE and Kuwait are showing increasing adoption for ELISA analyzer for better healthcare management.

ELISA Analyzers Market Segmentation



By type

Optical Filter Elisa Analyzer,

Optical Grating ELISA Analyzers

By Mode

Automated ELISA Analyzers,

Semi-Automated Analyzers

By Application


Vaccine development,

Drug Monitoring,



Biotechnology Companies,

Pharmaceutical Companies,

Contract Research Organization,

Diagnostic Laboratories


North America (U.S., Canada),

Europe (UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway)

Asia Pacific (Japan, China, India, Australia, Thailand, South Korea)

Latin America (Brazil, Mexico, Argentina),

Middle East & Africa (Saudi Africa, South Arabia, UAE, Kuwait)


The global ELISA analyzer market is highly competitive, with a large number of players operating in the space. Some of the top players in the market include Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, Danaher Corporation, BioTech, Agilent Technologies, QIAGEN, and PerkinElmer Inc. These companies have a strong presence in the market, their extensive product portfolios, broad geographic reach, and strong distribution networks. Additionally, many of these companies have invested heavily in research, development to stay ahead of the competition and offer the most advanced, and innovative ELISA analyzers to their customers.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon